Cargando…

Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens

Cervical cancer develops as a result of infection with high-risk human papillomavirus (HPV) through persistent expression of early proteins E6 and E7. Our group pioneered a recombinant viral vector system based on Semliki Forest virus (SFV) for vaccination against cervical cancer. The most striking...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Wall, Stephanie, Ljungberg, Karl, Ip, Peng Peng, Boerma, Annemarie, Knudsen, Maria L., Nijman, Hans W., Liljeström, Peter, Daemen, Toos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169581/ https://www.ncbi.nlm.nih.gov/pubmed/30288352 http://dx.doi.org/10.1080/2162402X.2018.1487913

Ejemplares similares

The Adjuvant Activity of Alphavirus Replicons Is Enhanced by Incorporating the Microbial Molecule Flagellin into the Replicon
por: Knudsen, Maria L., et al.
Publicado: (2013)

Alphavirus Replicon DNA Expressing HIV Antigens Is an Excellent Prime for Boosting with Recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 Protein Antigen
por: Knudsen, Maria L., et al.
Publicado: (2015)

A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development
por: Draghiciu, Oana, et al.
Publicado: (2015)

Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?
por: Koutsoumpli, Georgia, et al.
Publicado: (2019)

Epitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte Epitopes
por: Ip, Peng Peng, et al.
Publicado: (2015)

Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
por: Johansson, Daniel X., et al.
Publicado: (2012)

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7
por: van de Wall, Stephanie, et al.
Publicado: (2015)

DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost
por: Öhlund, Pontus, et al.
Publicado: (2018)

A Vaccinia Virus Recombinant Transcribing an Alphavirus Replicon and Expressing Alphavirus Structural Proteins Leads to Packaging of Alphavirus Infectious Single Cycle Particles
por: Sánchez-Puig, Juana M., et al.
Publicado: (2013)

Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle
por: Kamrud, K. I., et al.
Publicado: (2010)

Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660
por: Banerjee, K, et al.
Publicado: (2012)

Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity
por: Avogadri, Francesca, et al.
Publicado: (2010)

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers
por: Komdeur, Fenne L., et al.
Publicado: (2021)

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication
por: Draghiciu, Oana, et al.
Publicado: (2015)

From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors
por: Draghiciu, Oana, et al.
Publicado: (2011)

Alphavirus Replicon DNA Vectors Expressing Ebola GP and VP40 Antigens Induce Humoral and Cellular Immune Responses in Mice
por: Ren, Shoufeng, et al.
Publicado: (2018)

An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
por: Zhang, Hong-Qing, et al.
Publicado: (2022)

Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs
por: Oyarce, Cesar, et al.
Publicado: (2021)

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins
por: Wang, Min, et al.
Publicado: (2017)

Alphavirus Replicon Particle Vaccine Breaks B Cell Tolerance and Rapidly Induces IgG to Murine Hematolymphoid Tumor Associated Antigens
por: Su, Hsuan, et al.
Publicado: (2022)

Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
por: Draghiciu, Oana, et al.
Publicado: (2015)

DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice
por: Szurgot, Inga, et al.
Publicado: (2021)

Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis
por: Wang, Xiaoyan, et al.
Publicado: (2005)

Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay
por: Li, Jiangjiao, et al.
Publicado: (2012)

Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
por: Pohjala, Leena, et al.
Publicado: (2011)

Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands
por: Mollers, Madelief, et al.
Publicado: (2014)

DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection
por: Dalmia, Neha, et al.
Publicado: (2015)

An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats
por: Langereis, Martijn A., et al.
Publicado: (2021)

Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
por: Näslund, Tanja I, et al.
Publicado: (2011)

Correction: Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay
por: Li, Jiangjiao, et al.
Publicado: (2012)

Characterization of untranslated regions of the salmonid alphavirus 3 (SAV3) genome and construction of a SAV3 based replicon
por: Karlsen, Marius, et al.
Publicado: (2009)

Development and characterization of a Rift Valley fever virus cell–cell fusion assay using alphavirus replicon vectors
por: Filone, Claire Marie, et al.
Publicado: (2006)

Spindle-E Acts Antivirally Against Alphaviruses in Mosquito Cells
por: Varjak, Margus, et al.
Publicado: (2018)

P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes
por: Franti, M, et al.
Publicado: (2009)

A Polyprotein-Expressing Salmonid Alphavirus Replicon Induces Modest Protection in Atlantic Salmon (Salmo Salar) Against Infectious Pancreatic Necrosis
por: Abdullah, Azila, et al.
Publicado: (2015)

An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
por: Erasmus, Jesse H., et al.
Publicado: (2020)

A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

Riboflavin, a Potent Neuroprotective Vitamin: Focus on Flavivirus and Alphavirus Proteases
por: Eberle, Raphael J., et al.
Publicado: (2022)

Expanding the Hepatitis E Virus Toolbox: Selectable Replicons and Recombinant Reporter Genomes
por: Oechslin, Noémie, et al.
Publicado: (2023)

Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
por: Vermeij, Renee, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5r32mc8ooctovqvrnqlkpkdcr3